Tsutsui S, Hahn JN, Johnson TA, Ali Z, Jirik FR (2008) Absence of the cellular prion protein
exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyeli-
tis. Am J Pathol 173:1029–1041
Nasu-Nishimura Y, Taniuchi Y, Nishimura T, Sakudo A, Nakajima K, Ano Y, Sugiura K,
Sakaguchi S, Itohara S, Onodera T (2008) Cellular prion protein prevents brain damage after
encephalomyocarditis virus infection in mice. Arch Virol 153:1007–1012
Liu J, Zhao DM, Liu CF, Ding TJ, Yang LF, Yin XM, Zhou XM (2015) Prion protein partici-
pates in the protection of mice from lipopolysaccharide infection by regulating the inflamma-
tory process. J Mol Neurosci 55:279–287
Zhang J, Zeng Y, Zheng J, Xu J (2013) Expression of prion protein and its clinical signifi-
cance in oral squamous cells carcinoma and oral leukoplakia. Zhonghua kou qiang yi xue za
zhi = Zhonghua kouqiang yixue zazhi = Chin J Stomatology 48:752–754
Alfaidy N, Chauvet S, Donadio-Andrei S, Salomon A, Saoudi Y, Richaud P, Aude-Garcia C,
Hoffmann P, Andrieux A, Moulis JM, Feige JJ, Benharouga M (2013) Prion protein expres-
sion and functional importance in developmental angiogenesis: role in oxidative stress and
copper homeostasis. Antioxid Redox Signal 18:400–411
Al-Hilal TA, Chung SW, Choi JU, Alam F, Park J, Kim SW, Kim SY, Ahsan F, Kim IS, Byun
Y (2016) Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
J Clin Invest 126:1251–1266
Zhou L, Shang YL, Liu CH, Li JG, Hu H, Liang C, Han YA, Zhang W, Liang J, Wu KC
(2014) Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prog-
nosis in gastric cancer. Int J Cancer 135:2329–2337
Wang JH, Du JP, Zhang YH, Zhao XJ, Fan RY, Wang ZH, Wu ZT, Han Y (2011) Dynamic
changes and surveillance function of prion protein expression in gastric cancer drug resis-
tance. World J Gastroenterol 17:3986–3993
Tang Z, Ma J, Zhang W, Gong C, He J, Wang Y, Yu G, Yuan C, Wang X, Sun Y, Ma J, Liu F,
Zhao Y (2016) The role of prion protein expression in predicting gastric cancer prognosis.
J Cancer 7:984–990
Liang J, Wang JB, Pan YL, Wang J, Liu LL, Guo XY, Sun L, Lin T, Han S, Xie HH, Yin F,
Guo XG, Fan D (2006) High frequency occurrence of 1-OPRD variant of PRNP gene in
gastric cancer cell lines and Chinese population with gastric cancer. Cell Biol Int 30:920–923
Liang J, Pan YL, Ning XX, Sun LJ, Lan M, Hong L, Du JP, Liu N, Liu CJ, Qiao TD, Fan DM
(2006) Overexpression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol:
J Int Soc Oncodevelopmental Biol Med 27:84–91
Lopes MH, Santos TG, Rodrigues BR, Queiroz-Hazarbassanov N, Cunha IW, Wasilewska-
Sampaio AP, Costa-Silva B, Marchi FA, Bleggi-Torres LF, Sanematsu PI, Suzuki SH,
Oba-Shinjo SM, Marie SK, Toulmin E, Hill AF, Martins VR (2015) Disruption of prion
protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves
overall survival. Oncogene 34:3305–3314
Corsaro A, Bajetto A, Thellung S, Begani G, Villa V, Nizzari M, Pattarozzi A, Solari A, Gatti
M, Pagano A, Wurth R, Daga A, Barbieri F, Florio T. 2016. Cellular prion protein controls
stem cell-like properties of human glioblastoma tumor-initiating cells. Oncotarget
Sollazzo V, Galasso M, Volinia S, Carinci F (2012) Prion proteins (PRNP and PRND) are
over-expressed in osteosarcoma. J Orthop Res: Off Publ Orthop Res Soc 30:1004–1012
de Wit M, Jimenez CR, Carvalho B, Belien JA, Delis-van Diemen PM, Mongera S, Piersma
SR, Vikas M, Navani S, Ponten F, Meijer GA, Fijneman RJ (2012) Cell surface proteomics
identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal
adenoma-to-carcinoma progression. Gut 61:855–864
Antonacopoulou AG, Grivas PD, Skarlas L, Kalofonos M, Scopa CD, Kalofonos HP (2008)
POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prog-
nostic significance? Anticancer Res 28:1221–1227
Wei W, Shi Q, Zhang NS, Xiao K, Chen LN, Yang XD, Ji JF, Dong XP (2016) Expression of
prion protein is closely associated with pathological and clinical progression and abnormali-
ties of p53 in head and neck squamous cell carcinomas. Oncol Rep 35:817–824
